Exicure
Latest round
- Series C
Last raised
- Jan 2016
Total raised
- $5.4M
Investors
- 2
About Exicure
Exicure, Inc.Founded in 2011 and headquartered in Chicago, US, Exicure, Inc. focuses on developing advanced gene delivery technologies.Exicure specializes in the development of innovative therapeutics that concentrate on gene delivery and RNA-based technologies. Their core products include proprietary platforms that deliver therapeutic agents to target tissues, focusing on genetic disorders and cancers. The technology ensures high specificity and efficiency in targeting diseased cells, addressing limitations seen in traditional treatments.In 2024, Exicure reported a revenue of USD 500,000, with an EBITDA of USD -12,204,000. The company generates revenue through partnerships and collaborations with biopharmaceutical firms and research organizations, involving contractual agreements, milestone payments, and royalties on future sales of products developed using their technology. They are focused on expanding into additional markets in Europe and Asia by mid-2025.
Who invested in Exicure
2 investors across 3 rounds
See all investors in Exicure
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Exicure
Who invested in Exicure?
Exicure has 2 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Exicure raised?
Exicure has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Exicure last raise money?
Exicure's most recent round on record is a Series C, in Jan 2016.
What does Exicure do?
Exicure is a biotechnology company.
Where is Exicure headquartered?
Exicure is headquartered in Chicago, US.
Which VCs invest in companies like Exicure?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Exicure's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Exicure? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.